Refractory Acute lymphoblastic leukaemia
Also known as: Acute Lymphoblastic Leukemia Refractory / Acute, refractory Lymphocytic Leukemia / Acute, refractory Lymphoblastic Leukemia / Acute lymphocytic leukemia refractory / Acute, refractory Lymphoblastic Leukaemia / Refractory Acute Lymphoblastic Leukemia / Acute lymphocytic leukaemia refractory / Acute Lymphoblastic Leukemia, Refractory / Refractory Acute Lymphoblastic Leukemia (ALL) / Acute, refractory Lymphocytic leukaemia / Leukemia Lymphocytic Acute (All) Refractory
Drug | Drug Name | Drug Description |
---|---|---|
DB00631 | Clofarabine | A purine nucleoside used to treat relapsed or refractory acute lymphoblastic leukemia in patients 1 to 21 years old. |
DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |